Generics 10

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Levamlodipine manufacturers

10 products found

Filters

10 products found

levamlodipine + atenolol

Tablets 2.5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18431

Manufacturer usually replies in 1 days

levamlodipine

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18431

Manufacturer usually replies in 1 days

levamlodipine

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18057
It is a company established in the 2010s. The company operates in the Medicinal and Botanical Manufacturing sector.

Manufacturer usually replies in 2 days

levamlodipine + olmesartan medoxomil

Tablets 2.5/20mg, 2.5/40mg, 5/20mg, 5/40mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #13108
The company has a corporate mission of protecting precious human life from various forms of diseases. It is focused on improving the health status of the people. The company was established in the 1970s. They have grown in the ethical drug market specializing in IMDs and ophthalmic products.

Manufacturer usually replies in 5 days

levamlodipine

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19372

Manufacturer usually replies in 7 days

levamlodipine

Tablets 1.25 mg, 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

levamlodipine

Tablets 2.5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18707
It was established in the 1980s. The company has continued to attain strong growth and has sprung into a global biotech company with a continuous trade surplus in the global market. The company manufactures more than 150 pharmaceutical products, and approved products are more than 340 products from MFDS (Ministry of Food and Drug Safety). For the quality intensification and maximizing of productive capacity, the company completely equipped its manufacturing structure and facilities for producing pharmaceutical products guaranteed safety and effectiveness with stability.

Manufacturer usually replies in 30 days

levamlodipine

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #17943
The leading manufacturer in the pharma industry is through better medicine delivery. The company is known to procure raw materials and then use plants for chemical synthesis and fermentation and accordingly deliver medicinal supplies

Manufacturer usually replies in 15 days

nebivolol + levamlodipine

Tablets 5 mg+2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19017

Manufacturer usually replies in 3 days

nebivolol + levamlodipine

Tablets 5 mg+2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19508

Manufacturer usually replies in 9 days

S-Amlodipine

Levamlodipine (INN), more commonly known as amlodipine or S-amlodipine is a pharmacologically active enantiomer of amlodipine. This substance belongs to the dihydropyridine kind of calcium channel blockers used as an antihypertensive and antianginal agent

How does it work?

This substance is used with or without other medications for curing high blood pressure. Lessening high blood pressure helps prevent heart attacks, strokes, and kidney problems. The substance belongs to a group of drugs commonly known as calcium channel blockers.

The Price of S-Amlodipine

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the cost. The prices may vary from store to store.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of S-Amlodipine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for S-Amlodipine manufacturers and S-Amlodipine suppliers that you are looking for. These also enable you to check the dossier status of S-Amlodipine, and the GMP approvals of the different variants of S-Amlodipine. Also, each manufacturer or supplier product description contains essential information about S-Amlodipine including clinical data, stability zones, countries where S-Amlodipine is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are on boarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.